| Cell Phone Technology Targeting ART Adherence and Drug Use (NCT01884233) | University of California, Los Angeles | 2012-12-01 |
| Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women (NCT01749566) | Emory University | 2012-12-01 |
| Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients (NCT01766726) | Massachusetts General Hospital | 2012-12-01 |
| Expansion to Interdisciplinary HIV Prevention in Women (NCT01994603) | University of Oklahoma | 2012-12-01 |
| A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation (NCT02269462) | Adeniyi Olagunju | 2012-12-01 |
| Integrating HIV and Hepatitis C Screening in an Urban Emergency Department (NCT03252483) | New York City Health and Hospitals Corporation | 2012-12-01 |
| A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients. (NCT01736761) | St Stephens Aids Trust | 2012-12-01 |
| Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM (NCT01457066) | University of California, Los Angeles | 2012-12-01 |
| DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate (NCT01731574) | International Partnership for Microbicides, Inc. | 2012-12-01 |
| Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin (NCT01723527) | Johns Hopkins University | 2012-12-01 |
| Redirected MazF-CD4 Autologous T Cells for HIV Gene Therapy (NCT01787994) | University of Pennsylvania | 2012-12-01 |
| A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study (NCT01680536) | St Stephens Aids Trust | 2012-11-01 |
| A Risky Sex Prevention Intervention for Middle School Age Minority Girls (NCT02103218) | University of North Carolina, Greensboro | 2012-11-01 |
| Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus (NCT01760759) | UConn Health | 2012-11-01 |
| Observational Study of Male Circumcision Using PrePex Device (NCT01711411) | FHI 360 | 2012-11-01 |
| PRO 140 for Human Immunodeficiency Virus (NCT02438345) | Drexel University | 2012-11-01 |
| Pharmacogenomics of New Antiretrovirals (NCT02514369) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2012-11-01 |
| A Pilot Study on Raltegravir, Tenofovir and Emtricitabine for Peri-exposure Prophylaxis for HIV Infection (NCT01697046) | Projeto Praça Onze | 2012-11-01 |
| Barbershop Talk: HIV Prevention for African American Heterosexual Men (NCT01980771) | State University of New York - Downstate Medical Center | 2012-11-01 |
| Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) (NCT01637558) | University of Cape Town | 2012-11-01 |
| Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy (NCT01694017) | Tufts University | 2012-11-01 |
| A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives (NCT01935440) | Johns Hopkins Bloomberg School of Public Health | 2012-11-01 |
| A Pilot Trial of an Individualized Web-Based Condom Use Intervention (NCT01726153) | Centre hospitalier de l'Université de Montréal (CHUM) | 2012-11-01 |
| Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men (NCT01559805) | Columbia University | 2012-11-01 |
| Network Supported Engagement In HIV Care (NCT01726712) | University of Chicago | 2012-11-01 |
| A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique (NCT01697007) | Muhimbili University of Health and Allied Sciences | 2012-11-01 |
| Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi (NCT01650558) | University of Maryland, Baltimore | 2012-11-01 |
| Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis (NCT01707472) | Gilead Sciences | 2012-10-04 |
| Pre-exposure Option for Reducing HIV in the UK.(PROUD) (NCT02065986) | MRC [ycm] | 2012-10-01 |
| Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana (NCT01687504) | The Miriam Hospital | 2012-10-01 |
| Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination (NCT01650389) | Mark Hatherill | 2012-10-01 |
| First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers (NCT01719627) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2012-10-01 |
| Fistula Formation and Successful Repair (NCT02770352) | University of North Carolina, Chapel Hill | 2012-10-01 |
| Rifampin and Nevirapine Interactions in Young Children (NCT01699633) | The Miriam Hospital | 2012-10-01 |
| Body Image in Youth With HIV (NCT01673750) | St. Jude Children's Research Hospital | 2012-10-01 |
| Rifampin and Efavirenz Interactions in Older Children (NCT01704144) | The Miriam Hospital | 2012-10-01 |
| Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services (NCT01691768) | Centre for the AIDS Programme of Research in South Africa | 2012-10-01 |
| Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease (NCT01654939) | Douglas T. Dieterich | 2012-10-01 |
| Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals (NCT01712425) | IrsiCaixa | 2012-10-01 |
| Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen (NCT01705873) | Helios Salud | 2012-09-01 |
| A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine (NCT01701882) | St Stephens Aids Trust | 2012-09-01 |
| Reducing High Risk Behavior in Treatment Court (NCT01481428) | Treatment Research Institute | 2012-09-01 |
| Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet (NCT01694420) | Duke University | 2012-09-01 |
| Healthy Beginning Initiative (NCT01795261) | University of Nevada, Reno | 2012-09-01 |
| Secondary HIV Prevention and Adherence Among HIV-infected Drug Users (NCT01741311) | University of Connecticut | 2012-09-01 |
| Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan (NCT01697540) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2012-09-01 |
| Clinical Outcomes of People Who Acquired HIV in Early Life (NCT01656564) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-27 |
| Patient-Centered Disclosure Intervention for HIV-Infected Children (NCT01947764) | Indiana University | 2012-08-01 |
| A Couple-Based Relationship Strengthening HIV Intervention for Young Parents (NCT01643005) | Yale University | 2012-08-01 |
| Improving Blood Safety and HIV Testing in Brazil (NCT01681420) | Vitalant Research Institute | 2012-08-01 |
| ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment (NCT01671982) | Institut de Recherche pour le Developpement | 2012-08-01 |
| ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART (NCT01683656) | Calmy Alexandra | 2012-08-01 |
| Evaluation of Use of Clinical Decision Support System in HIV Care in Resource Constrained Settings (NCT01634802) | Kenya Medical Research Institute | 2012-08-01 |
| Mobile Phone Text Messaging Referral (NCT01746758) | Liverpool School of Tropical Medicine | 2012-08-01 |
| Brazilian HIV/Sexually Transmitted Infection (STI) Prevention for Adolescents With Mental Health Disorder (NCT01854853) | New York State Psychiatric Institute | 2012-08-01 |
| Optimizing Clinical Outcomes in HIV-Infected Adults & Children (NCT02043080) | University of North Carolina, Chapel Hill | 2012-08-01 |
| Antimalarial Pharmacology in Children and Pregnant Women in Uganda (NCT01717885) | University of California, San Francisco | 2012-08-01 |
| Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC (NCT01620944) | Bristol-Myers Squibb | 2012-07-31 |
| Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda (NCT01579214) | Massachusetts General Hospital | 2012-07-01 |
| Abacavir and Lamivudine PK in Children (NCT01656122) | The HIV Netherlands Australia Thailand Research Collaboration | 2012-07-01 |
| Enhancing Quality Interventions Promoting Healthy Sexuality (NCT01818791) | RAND | 2012-07-01 |
| Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM (NCT01394900) | Columbia University | 2012-07-01 |
| Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users (NCT01612169) | Columbia University | 2012-07-01 |
| Pilot Study of Immediate HIV Treatment in Guangxi, China (NCT01892228) | National Center for AIDS/STD Control and Prevention, China CDC | 2012-07-01 |
| Choices-Teen: A Bundled Risk Reduction Intervention for Juvenile Justice Females (NCT02252471) | University of Houston | 2012-07-01 |
| Eban II: Intervention for HIV Sero-Discordant Couples (NCT01829282) | University of California, Los Angeles | 2012-07-01 |
| Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir (NCT01597180) | University of North Carolina, Chapel Hill | 2012-07-01 |
| Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone (NCT01605084) | Bristol-Myers Squibb | 2012-06-30 |
| Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa (NCT02439918) | Université de Sherbrooke | 2012-06-01 |
| Thol'Impilo: Bringing People Into Care (NCT02271074) | The Aurum Institute NPC | 2012-06-01 |
| MARCH Renal Substudy (NCT01637259) | Kirby Institute | 2012-06-01 |
| Assisted Partner Notification to Augment HIV Treatment and Prevention in Kenya (NCT01616420) | University of Washington | 2012-06-01 |
| Preliminary Evaluation of a Point-Of-Care Liver Function Test (NCT01705041) | PATH | 2012-06-01 |
| The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception (NCT01667978) | University of Southern California | 2012-06-01 |
| Kumasi Cohort Study (NCT01853657) | Bernhard Nocht Institute for Tropical Medicine | 2012-06-01 |
| Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment (NCT01376570) | Albert Einstein College of Medicine | 2012-06-01 |
| Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® (NCT01591902) | Theratechnologies | 2012-06-01 |
| WHC+ (Women's Health CoOp PLUS) (NCT01497405) | RTI International | 2012-05-01 |
| Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis (NCT01635153) | Dartmouth-Hitchcock Medical Center | 2012-05-01 |
| Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz (NCT01695954) | NYU Langone Health | 2012-05-01 |
| Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline (NCT02086630) | New York University | 2012-05-01 |
| Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa (NCT01715922) | ANRS, Emerging Infectious Diseases | 2012-05-01 |
| Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily (NCT01581853) | Daniel Podzamczer | 2012-05-01 |
| Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV (NCT01125696) | Centers for Disease Control and Prevention | 2012-05-01 |
| Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men (NCT01751594) | University of North Carolina, Chapel Hill | 2012-04-01 |
| Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART) (NCT01591252) | University of Alabama at Birmingham | 2012-04-01 |
| Project Wellness: Increasing HIV Testing Among West African Immigrants (NCT01270061) | North Bronx Healthcare Network | 2012-04-01 |
| Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya (NCT01548599) | University of California, San Francisco | 2012-04-01 |
| Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk (NCT01510262) | University of Wisconsin, Milwaukee | 2012-04-01 |
| Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events (NCT01699841) | Cornell University | 2012-04-01 |
| The Role of Genital Warts in HIV Acquisition in Peru (NCT01387412) | University of California, Los Angeles | 2012-04-01 |
| Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients (NCT01645033) | Yale University | 2012-04-01 |
| Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth (NCT01647841) | Cornell University | 2012-04-01 |
| Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up (NCT01667068) | University Hospital, Essen | 2012-04-01 |
| Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique (NCT02371265) | University of Washington | 2012-04-01 |
| Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients. (NCT01565889) | Gilead Sciences | 2012-03-01 |
| A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir (NCT01255371) | ANRS, Emerging Infectious Diseases | 2012-03-01 |
| The Rilpivirine Cerebrospinal-fluid (CSF) Study (NCT01562886) | Imperial College London | 2012-03-01 |
| ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study (NCT01535235) | University of California, San Francisco | 2012-02-01 |
| Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection (NCT02166502) | The Hospital for Sick Children | 2012-02-01 |